Possible neural mechanisms involved in footshock stress-induced enhancement of exploratory behavior in mice

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 4, 1999, Pages 418-421

  Kohno, Hiroyuki ^a   Katayama, Susumu ^a   Ohuchi, Yukie ^a   Ohkubo, Yasuhito ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Ambulatory activation; Footshock stress; Neural mechanism; Open field

Indexed keywords

ATROPINE; DIAZEPAM; DIZOCILPINE; HALOPERIDOL; MIANSERIN; NALTREXONE; PHENTOLAMINE; PROPRANOLOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOBILIZATION; MOUSE; NEUROTRANSMISSION; NONHUMAN; OPEN FIELD BEHAVIOR; SHOCK; STRESS;

EID: 0032947457     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.418     Document Type: Article

References (33)

1. Stanford S. C., "Stress: From Synapse to Syndrome," eds. by Stanford S. C. , Salmon P., Academic Press, London, 1993, pp. 281-331.
2. Sutanto W., De Kloet R., "Stress: From Synapse to Syndrome," eds. by Stanford S. C. , Salmon P., Academic Press, London, 1993, pp. 333-354.
3. Hayden-Hixson D. M., Nemeroff C. B., "Stress: From Synapse to Syndrome," eds. by Stanford S. C., Salmon P., Academic Press, London, 1993, pp. 355-391.
4. Brown G. W., "Stress: From Synapse to Syndrome," eds. by Stanford S. C., Salmon P., Academic Press, London, 1993, pp. 23-50.
5. Glue P., Nutt D., Coupland N., "Stress: From Synapse to Syndrome," eds. by Stanford S. C. , Salmon P., Academic Press, London, 1993, pp. 53-73.
6. Roth K. A., Katz R. J., Neurosci. Behav. Rev., 3, 247-263 (1979).
7. Katz R. J., Roth K. A., Carroll B. J., Neurosci. Behav. Rev., 5, 247-251 (1981).
8. Nabeshima T., Yamada K., Kameyama T., Eur. J. Pharmacol., 92, 199-205 (1983).
9. Plaznik A., Stefanski R., Pucilowski O., Kostowski W., J. Pharm. Pharmacol., 42, 79-84 (1990).
10. Lee E. H. Y., Tsai M. J., Chai C. Y., Physiol. Behav., 37, 659-662 (1986).
11. Van Dijken H. H., Van der Heyden J. A., Mos J., Tilders F. J., Physiol. Behav., 51, 787-794 (1992).
12. Kohno H., Ohkubo Y., Biol. Pharm. Bull., 21, 113-116 (1998).
13. Herman J. P., Guillonneau D., Dantzer R., Scatton B., Semerdjian-Rouquier L., Le Moal M., Life Sci., 30, 2207-2214 (1982).
14. Fink J. S., Smith G. P., Brain Res., 199, 359-384 (1980).
15. Sara S. J., Dyon-Laurent C., Herve A., Cognitive Brain Res., 2, 181-187 (1995).
16. Iimori K., Tanaka M., Kohno Y., Ida Y., Nakagawa R., Hoaki Y., Tsuda A., Nagasaki N., Pharmacol. Biochem. Behav., 16, 637-640 (1982).
17. Glavin G. B., Tanaka M., Tsuda A., Kohno Y., Hoaki Y., Nagasaki N., Pharmacol. Biochem. Behav., 19, 287-290 (1983).
18. Stanford S. C., Pharmacol. Biochem. Behav., 54, 211-217 (1996).
19. Franklin S. R., Tang A. H., Psychopharmacology, 121, 480-484 (1995).
20. Dunn A. J., Life Sci., 42, 1847-1853 (1988).
21. Rueter L. E., Fornal C. A., Jacobs B. L., Rev. Neurosci., 8, 117-137 (1997).
22. Mark G. P., Rada P. V., Shors T. J., Neuroscience, 74, 767-774 (1996).
23. Day J., Damsma G., Fibiger H. C., Pharmacol. Biochem. Behav., 38, 723-729 (1991).
24. Giovannini M. G., Bartolini L., Kopf S. R., Pepeu G., Brain Res., 784, 218-227 (1998).
25. Acosta G. B., Rubio M. C., Neurosci. Lett., 176, 29-31 (1994).
26. Concas A., Mele S., Biggio G., Eur. J. Pharmacol., 135, 423-427 (1987).
27. Concas A., Sanna E., Cuccheddu T., Mascia M. P., Santoro G., Maciocco E., Biggio G., Prog. Neuropsychopharmacol. Biol. Psychiatry, 17, 651-661 (1993).
28. Yamada K., Nabeshima T., Behav. Brain Res., 67, 133-145 (1995).
29. Nabeshima T., Matsuno K., Kameyama T., Eur. J. Pharmacol., 114, 197-207 (1985).
30. Palkovits M., Lang T., Patthy A., Elekes I., Brain Res., 373, 252-257 (1986).
31. Moghaddam B., J. Neurochem., 60, 1650-1657 (1993).
32. Saulskaya N., Marsden C. A., Brain Res., 698, 114-120 (1995).
33. O'neill K. A., Carelli R. M., Jarvis M. F., Liebman J. M., Pharmacol. Biochem. Behav., 34, 739-745 (1989).